Medicus Pharma Ltd (MDCX)
NASDAQ:MDCX
Medicus Pharma Ltd (MDCX) Ownership Overview
13.79% Insiders
0.01% Mutual Funds
13.57% Other Institutional Investors
0.14% ETFs
72.49% Public Companies and
Individual Investors
The ownership structure of Medicus Pharma Ltd (MDCX) stock is a mix of institutional, retail, and individual investors. Approximately 13.72% of the company’s stock is owned by Institutional Investors, 13.79% is owned by Insiders, and 72.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 21, 2025 | xxxxxxxxxxxxx | $578250 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,248,741 | Insider | 12.72% | 1,624,371 | |
| 274,147 | Insider | 1.07% | 137,074 | |
| 35,015 | Institution | 0.14% | 17,508 | |
| 3,745 | Institution | 0.01% | 1,873 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,745 | Institution | 0.01% | 1,873 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 35,015 | Institution | 0.14% | 17,508 |
FAQ
Who Owns Medicus Pharma Ltd (MDCX)?
According to the latest TipRanks data, approximately 13.57% of the company's stock is held by institutional investors, 13.79% is held by insiders, and 72.49% is held by retail investors.
What percentage of Medicus Pharma Ltd (MDCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.57% of Medicus Pharma Ltd (MDCX) stock is held by institutional investors.
What percentage of Medicus Pharma Ltd (MDCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.49% of Medicus Pharma Ltd (MDCX) stock is held by retail investors.
Who owns the most shares of Medicus Pharma Ltd (MDCX)?
VELOCITY FUND PARTNERS, LP owns the most shares of Medicus Pharma Ltd (MDCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.